Nan Fung Group Holdings Ltd - RHYTHM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Nan Fung Group Holdings Ltd ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$918,605
+39.0%
40,0700.0%0.74%
+76.3%
Q2 2023$660,754
+13.9%
40,070
+23.2%
0.42%
+6.8%
Q1 2023$580,157
-38.7%
32,5200.0%0.40%
-39.4%
Q4 2022$946,98232,5200.65%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 4,909,956$142,977,9198.04%
Opaleye Management Inc. 735,000$21,403,2007.44%
Frazier Life Sciences Management, L.P. 1,894,000$55,153,2803.43%
RA Capital Management 5,516,067$160,627,8713.26%
Altium Capital Management LP 170,000$4,950,4002.52%
Samsara BioCapital, LLC 345,293$10,054,9322.16%
Rock Springs Capital Management LP 1,760,865$51,276,3891.23%
Parkman Healthcare Partners LLC 157,862$4,596,9411.22%
Baker Brothers Advisors 6,354,608$185,046,1851.11%
EAM Investors, LLC 164,695$4,795,9180.99%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders